Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Jan. 01, 2011
Jan. 02, 2010
Cash flows from operating activities:      
Net income $ 37,677 $ 21,400 $ 1,856
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 6,721 6,873 6,968
(Gain) loss on disposal of assets (32) (43) 30
Gain on Investment in HCT (1,244)    
Stock-based compensation expense 1,752 1,149 960
Deferred director and phantom stock unit expense (income) (22) 557 398
Stock compensation income tax benefit (144) (175) (9)
Allowance for doubtful accounts 1 (8) (2)
Provision for slow moving inventory (19) (159) (41)
Provision for deferred income taxes 1,419 622 4
(Increase) decrease in:      
Accounts receivable 741 (6,442) 2,555
Inventories (1,593) (2,815) 2,202
Income tax receivable 1,178 506 (123)
Other current assets (662) (759) (507)
Other assets, net (1,081) 750 560
Increase (decrease) in:      
Accounts payable 499 861 (816)
Accrued expenses and other liabilities 4,390 2,775 (672)
Other noncurrent liabilities (37) (2) 304
Net cash from operating activities 49,544 25,090 13,667
Cash flows from investing activities:      
Sale of China joint venture 1,451    
Investment in HCT (1,776)    
Capital expenditures (10,143) (3,856) (5,096)
Proceeds from dispositions of equipment 35 175  
Purchases of marketable securities (18,405) (14,175) (10,600)
Proceeds from sale of marketable securities 7,517 10,230 2,863
Net cash used in investing activities (21,321) (7,626) (12,833)
Cash flows from financing activities:      
Repayment of debt (100)   (261)
Proceeds from exercise of stock options 61 44 11
Stock compensation income tax benefit 144 175 9
Proceeds from stock issued 574 423 392
Dividends to shareholders (9,596) (14,635) (7,547)
Net cash used in financing activities (8,917) (13,993) (7,396)
Effect of exchange rate changes on cash and cash equivalents (1,335) (580) 1,705
Net increase (decrease) in restricted cash (85) (1) 5
Net increase (decrease) in cash and cash equivalents 18,056 2,892 (4,862)
Cash and cash equivalents and restricted cash, beginning of period 33,337 30,446 35,303
Cash and cash equivalents and restricted cash, end of period 51,308 33,337 30,446
Supplemental disclosure of cash flow information:      
Interest     9
Income taxes 17,456 9,290 289
Supplemental disclosure of noncash transactions:      
Common stock issued to ESOP through accrued expenses and other liabilities 2,412   2,796
Unrealized gain (loss) on available for sale securities $ (549) $ (59) $ 116